Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
May-2018 Volume 17 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2018 Volume 17 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Secretome analysis of rat osteoblasts during icariin treatment induced osteogenesis

  • Authors:
    • Weiqing Qian
    • Yan Su
    • Yajie Zhang
    • Nianwei Yao
    • Nin Gu
    • Xu Zhang
    • Hong Yin
  • View Affiliations / Copyright

    Affiliations: Department of Orthopedics, The 3rd Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210001, P.R. China, Reproductive Center, Obstetrics and Gynecology Hospital Affiliated to Nanjing Medical University, Nanjing, Jiangsu 210023, P.R. China, Laboratory Center, The 3rd Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, P.R. China, Cardiovascular Department, The 3rd Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, P.R. China, School of Medicine and Life Sciences, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, P.R. China
    Copyright: © Qian et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 6515-6525
    |
    Published online on: March 9, 2018
       https://doi.org/10.3892/mmr.2018.8715
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Osteoporosis is a serious public health problem and icariin (ICA) is the active component of the Epimedium sagittatum, a traditional Chinese medicinal herb. The present study aimed to investigate the effects and underlying mechanisms of ICA as a potential therapy for osteoporosis. Calvaria osteoblasts were isolated from newborn rats and treated with ICA. Cell viability, apoptosis, alkaline phosphatase activity and calcium deposition were analyzed. Bioinformatics analyses were performed to identify differentially expressed proteins (DEPs) in response to ICA treatment. Western blot analysis was performed to validate the expression of DEPs. ICA administration promoted osteoblast viability, alkaline phosphatase activity, calcium deposition and inhibited osteoblast apoptosis. Secretome analysis of ICA‑treated cells was performed using two‑dimensional gel electrophoresis and matrix‑assisted laser desorption/ionization time‑of‑flight mass spectrometry. A total of 56 DEPs were identified, including serpin family F member 1 (PEDF), protein disulfide isomerase family A, member 3 (PDIA3), nuclear protein, co‑activator of histone transcription (NPAT), c‑Myc and heat shock protein 70 (HSP70). These proteins were associated with signaling pathways, including Fas and p53. Bioinformatics and western blot analyses confirmed that the expression levels of the six DEPs were upregulated following ICA treatment. These genes may be directly or indirectly involved in ICA‑mediated osteogenic differentiation and osteogenesis. It was demonstrated that ICA treatment promoted osteogenesis by modulating the expression of PEDF, PDIA3, NPAT and HSP70 through signaling pathways, including Fas and p53.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Odén A, McCloskey EV, Kanis JA, Harvey NC and Johansson H: Burden of high fracture probability worldwide: Secular increases 2010–2040. Osteoporos Int. 26:2243–2248. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Zambelli PY, Tercier S, Newman CJ and Bregou A: Targeted approach to osteoporosis for children and teenagers. Rev Med Suisse. 10:116–118. 2014.(In French). PubMed/NCBI

3 

Tyagi AM, Srivastava K, Mansoori MN, Trivedi R, Chattopadhyay N and Singh D: Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: A new candidate in the pathogenesis of osteoporosis. PLoS One. 7:e445522012. View Article : Google Scholar : PubMed/NCBI

4 

Kurt-Sirin O, Yilmaz-Aydogan H, Uyar M, Seyhan MF, Isbir T and Can A: Combined effects of collagen type I alpha1 (COL1A1) Sp1 polymorphism and osteoporosis risk factors on bone mineral density in Turkish postmenopausal women. Gene. 540:226–231. 2014. View Article : Google Scholar : PubMed/NCBI

5 

Cheung A, Papaioannou A and Morin S: Osteoporosis Canada Scientific Advisory Council: Postmenopausal osteoporosis. N Engl J Med. 374:20962016.PubMed/NCBI

6 

Chen H, Liu N, Xu X, Qu X and Lu E: Smoking, radiotherapy, diabetes and osteoporosis as risk factors for dental implant failure: A meta-analysis. PLoS One. 8:e719552013. View Article : Google Scholar : PubMed/NCBI

7 

Miyamoto T: Mechanism underlying post-menopausal osteoporosis: HIF1α is required for osteoclast activation by estrogen deficiency. Keio J Med. 64:44–47. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Ahn HJ, Kim HJ, Kim YS, Kim MS, Huh KH, Kim JH, Lee JH, Jeon KO and Kim SI: Risk factors for changes in bone mineral density and the effect of antiosteoporosis management after renal transplantation. Transplant Proc. 38:pp. 2074–2076. 2006; View Article : Google Scholar : PubMed/NCBI

9 

Díez-Pérez A, Adachi JD, Adami S, Anderson FA Jr, Boonen S, Chapurlat R, Compston JE, Cooper C, Gehlbach SH, Greenspan SL, et al: Risk factors for treatment failure with antiosteoporosis medication: The global longitudinal study of osteoporosis in women (GLOW). J Bone Miner Res. 29:260–267. 2014. View Article : Google Scholar : PubMed/NCBI

10 

Lee MK, Choi YJ, Sung SH, Shin DI, Kim JW and Kim YC: Antihepatotoxic activity of icariin, a major constituent of Epimedium koreanum. Planta Med. 61:523–526. 1995. View Article : Google Scholar : PubMed/NCBI

11 

Chen KM, Ge BF, Ma HP, Liu XY, Bai MH and Wang Y: Icariin, a flavonoid from the herb Epimedium enhances the osteogenic differentiation of rat primary bone marrow stromal cells. Pharmazie. 60:939–942. 2005.PubMed/NCBI

12 

Meng FH, Li YB, Xiong ZL, Jiang ZM and Li FM: Osteoblastic proliferative activity of Epimedium brevicornum Maxim. Phytomedicine. 12:189–193. 2005. View Article : Google Scholar : PubMed/NCBI

13 

Xue L, Wang Y, Jiang Y, Han T, Nie Y, Zhao L, Zhang Q and Qin L: Comparative effects of er-xian decoction, epimedium herbs, and icariin with estrogen on bone and reproductive tissue in ovariectomized rats. Evid Based Complementary Altern Med. 2012:2414162012. View Article : Google Scholar

14 

Yang L, Lu D, Guo J, Meng X, Zhang G and Wang F: Icariin from Epimedium brevicornum Maxim promotes the biosynthesis of estrogen by aromatase (CYP19). J Ethnopharmacol. 145:715–721. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Chen G, Wang C, Wang J, Yin S, Gao H, Xiang LU, Liu H, Xiong Y, Wang P, Zhu X, et al: Antiosteoporotic effect of icariin in ovariectomized rats is mediated via the Wnt/β-catenin pathway. Exp Ther Med. 12:279–287. 2016. View Article : Google Scholar : PubMed/NCBI

16 

Liu H, Xiong Y, Zhu X, Gao H, Yin S, Wang J, Chen G, Wang C, Xiang L, Wang P, et al: Icariin improves osteoporosis, inhibits the expression of PPARγ, C/EBPα, FABP4 mRNA, N1ICD and jagged1 proteins, and increases Notch2 mRNA in ovariectomized rats. Exp Ther Med. 13:1360–1368. 2017. View Article : Google Scholar : PubMed/NCBI

17 

Li XF, Xu H, Zhao YJ, Tang DZ, Xu GH, Holz J, Wang J, Cheng SD, Shi Q and Wang YJ: Icariin augments bone formation and reverses the phenotypes of osteoprotegerin-deficient mice through the activation of Wnt/β-catenin-BMP signaling. Evid Based Complementary Altern Med. 2013:6523172013. View Article : Google Scholar

18 

Xue L, Jiang Y, Han T, Zhang N, Qin L, Xin H and Zhang Q: Comparative proteomic and metabolomic analysis reveal the antiosteoporotic molecular mechanism of icariin from Epimedium brevicornu maxim. J Ethnopharmacol. 192:370–381. 2016. View Article : Google Scholar : PubMed/NCBI

19 

Bakker A and Klein-Nulend J: Osteoblast isolation from murine calvariae and long bones. Methods Mol Med. 80:19–28. 2013.

20 

Chang H, Jin TY, Jin WF, Gu SZ and Zhou YF: Modulation of isoflavones on bone-nodule formation in rat calvaria osteoblasts in vitro. Biomed Environ Sci. 16:83–89. 2003.PubMed/NCBI

21 

Honda H, Tamai N, Naka N, Yoshikawa H and Myoui A: Bone tissue engineering with bone marrow-derived stromal cells integrated with concentrated growth factor in Rattus norvegicus calvaria defect model. J Artif Organs. 16:305–315. 2013. View Article : Google Scholar : PubMed/NCBI

22 

Coutu DL, Wu JH, Monette A, Rivard GE, Blostein MD and Galipeau J: Periostin, a member of a novel family of vitamin K-dependent proteins, is expressed by mesenchymal stromal cells. J Biol Chem. 283:17991–18001. 2008. View Article : Google Scholar : PubMed/NCBI

23 

Zhao Y, Ju F, Zhao Y, Wang L, Sun Z, Liu M and Gao L: The expression of αA- and βB1-crystallin during normal development and regeneration, and proteomic analysis for the regenerating lens in Xenopus laevi. Mol Vis. 17:768–778. 2011.PubMed/NCBI

24 

Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248–254. 1976. View Article : Google Scholar : PubMed/NCBI

25 

Xing X, Lai M, Gartner W, Xu E, Huang Q, Li H and Chen G: Identification of differentially expressed proteins in colorectal cancer by proteomics: Down-regulation of secretagogin. Proteomics. 6:2916–2923. 2006. View Article : Google Scholar : PubMed/NCBI

26 

Ma X, Liu G, Wang S, Chen Z, Lai M, Liu Z and Yang J: Evaluation of sphingolipids changes in brain tissues of rats with pentylenetetrazol-induced kindled seizures using MALDI-TOF-MS. J Chromatogr B Analyt Technol Biomed Life Sci. 859:170–177. 2007. View Article : Google Scholar : PubMed/NCBI

27 

Powell TJ, Strutt T, Reome J, Hollenbaugh JA, Roberts AD, Woodland DL, Swain SL and Dutton RW: Priming with cold-adapted influenza A does not prevent infection but elicits long-lived protection against supralethal challenge with heterosubtypic virus. J Immunol. 178:1030–1038. 2007. View Article : Google Scholar : PubMed/NCBI

28 

Mi H, Muruganujan A, Casagrande JT and Thomas PD: Large-scale gene function analysis with the PANTHER classification system. Nat Protoc. 8:1551–1566. 2013. View Article : Google Scholar : PubMed/NCBI

29 

Mi H and Thomas P: PANTHER pathway: An ontology-based pathway database coupled with data analysis tools. Methods Mol Biol. 563:123–140. 2009. View Article : Google Scholar : PubMed/NCBI

30 

Bogan R, Riddle RC, Li Z, Kumar S, Nandal A, Faugere MC, Boskey A, Crawford SE and Clemens TL: A mouse model for human osteogenesis imperfecta type VI. J Bone Miner Res. 28:1531–1536. 2013. View Article : Google Scholar : PubMed/NCBI

31 

Gattu AK, Swenson ES, Iwakiri Y, Samuel VT, Troiano N, Berry R, Church CD, Rodeheffer MS, Carpenter TO and Chung CH: Determination of mesenchymal stem cell fate by pigment epithelium-derived factor (PEDF) results in increased adiposity and reduced bone mineral content. FASEB J. 27:4384–4394. 2013. View Article : Google Scholar : PubMed/NCBI

32 

Doroudi M: Essential roles of Pdia3/PLAA receptor complex and CaMKII IN 1α,25(OH)2D3 and Wnt5a calcium-dependent signaling pathways in osteoblasts and chondrocytes. 2014.

33 

Frank SR, Schroeder M, Fernandez P, Taubert S and Amati B: Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev. 15:2069–2082. 2001. View Article : Google Scholar : PubMed/NCBI

34 

Kaibuchi K, Tsuda T, Kikuchi A, Tanimoto T, Yamashita T and Takai Y: Possible involvement of protein kinase C and calcium ion in growth factor-induced expression of c-myc oncogene in Swiss 3T3 fibroblasts. J Biol Chem. 261:1187–1192. 1986.PubMed/NCBI

35 

Vadde R, Radhakrishnan S, Kurundu HEK, Reddivari L and Vanamala JK: Indian gooseberry (Emblica officinalis Gaertn.) suppresses cell proliferation and induces apoptosis in human colon cancer stem cells independent of p53 status via suppression of c-Myc and cyclin D1. J Funct Foods. 25:267–278. 2016. View Article : Google Scholar

36 

Zhang W, Shen X, Wan C, Zhao Q, Zhang L, Zhou Q and Deng L: Effects of insulin and insulin-like growth factor 1 on osteoblast proliferation and differentiation: differential signalling via Akt and ERK. Cell Biochem Funct. 30:297–302. 2012. View Article : Google Scholar : PubMed/NCBI

37 

Chen BJ, Wu YL, Tanaka Y and Zhang W: Small molecules targeting c-Myc oncogene: promising anti-cancer therapeutics. Int J Biol Sci. 10:1084–1096. 2014. View Article : Google Scholar : PubMed/NCBI

38 

Zirath H, Frenzel A, Oliynyk G, Segerström L, Westermark UK, Larsson K, Munksgaard Persson M, Hultenby K, Lehtiö J, Einvik C, et al: MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells. Proc Natl Acad Sci USA. 110:pp. 10258–10263. 2013; View Article : Google Scholar : PubMed/NCBI

39 

Banerjee D, Upadhyay RC, Chaudhary UB, Kumar R, Singh S, Ashutosh G JM, Polley S, Mukherjee A, Das TK and De S: Seasonal variation in expression pattern of genes under HSP70: Seasonal variation in expression pattern of genes underHSP70 family in heat- and cold-adapted goats (Capra hircus). Cell Stress Chaperones. 19:401–408. 2014. View Article : Google Scholar : PubMed/NCBI

40 

Qian W, Yin H and Sun H: Influence of different concentrations of Icariin on osteoblast metabolism of rats. China Med Herald. 8:23–25. 2011.(In Chinese).

41 

Song L, Zhao J, Zhang X, Li H and Zhou Y: Icariin induces osteoblast proliferation, differentiation and mineralization through estrogen receptor-mediated ERK and JNK signal activation. Eur J Pharmacol. 714:15–22. 2013. View Article : Google Scholar : PubMed/NCBI

42 

Cao H, Ke Y, Zhang Y, Zhang CJ, Qian W and Zhang GL: Icariin stimulates MC3T3-E1 cell proliferation and differentiation through up-regulation of bone morphogenetic protein-2. Int J Mol Med. 29:435–439. 2012.PubMed/NCBI

43 

Zhang DW, Cheng Y, Wang NL, Zhang JC, Yang MS and Yao XS: Effects of total flavonoids and flavonol glycosides from Epimedium koreanum Nakai on the proliferation and differentiation of primary osteoblasts. Phytomedicine. 15:55–61. 2008. View Article : Google Scholar : PubMed/NCBI

44 

Duan P, Hu C, Butler HJ, Quan C, Chen W, Huang W, Tang S, Zhou W, Yuan M, Shi Y, et al: 4-Nonylphenol induces disruption of spermatogenesis associated with oxidative stress-related apoptosis by targeting p53-Bcl-2/Bax-Fas/FasL signaling. Environ Toxicol. 32:739–753. 2017. View Article : Google Scholar : PubMed/NCBI

45 

Han Y, Jiang Q, Wang Y, Li W, Geng M, Han Z and Chen X: The anti-proliferative effects of oleanolic acid on A7r5 cells-Role of UCP2 and downstream FGF-2/p53/TSP-1. Cell Biol Int. 41:1296–1306. 2017. View Article : Google Scholar : PubMed/NCBI

46 

Zhang SX, Wang JJ, Gao G, Shao C, Mott R and Ma JX: Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor. FASEB J. 20:323–325. 2006. View Article : Google Scholar : PubMed/NCBI

47 

Jarvis CL, Nelius T, Martinez-Marin D, Cheerla S and Filleur S: Low-dose cabazitaxel inhibits the growth of prostate cancer cells and enhances the anti-tumor properties of PEDF with greater efficacy than docetaxel. Cancer Res. 76:2882016. View Article : Google Scholar

48 

Nelius T, Hirsch J and Filleur S: PEDF inhibits bone metastases formation, prolongs survival and enhances the antitumor efficacy of low-dose chemotherapy in castration-refractory prostate cancer. Cancer Res. 73:50972013. View Article : Google Scholar

49 

Ho TC, Chen SL, Yang YC, Liao CL, Cheng HC and Tsao YP: PEDF induces p53-mediated apoptosis through PPAR gamma signaling in human umbilical vein endothelial cells. Cardiovasc Res. 76:213–223. 2007. View Article : Google Scholar : PubMed/NCBI

50 

Sun H, Kim JK, Mortensen R, Mutyaba LP, Hankenson KD and Krebsvach PH: Osteoblast-targeted suppression of PPARγ increases osteogenesis through activation of mTOR signaling. Stem Cells. 31:2183–2192. 2013. View Article : Google Scholar : PubMed/NCBI

51 

Brusotti G, Montanari R, Capelli D, Cattaneo G, Laghezza A, Tortorella P, Loiodice F, Peiretti F, Bonardo B, Paiardini A, et al: Betulinic acid is a PPARγ antagonist that improves glucose uptake, promotes osteogenesis and inhibits adipogenesis. Scienti Rep. 7:57772017. View Article : Google Scholar

52 

Ling Zheng L, Wang FY, Cong XX, Shen Y, Rao XS, Huang DS, Fan W, Yi P, Wang XB, Zheng L, et al: Interaction of heat shock protein Cpn10 with the Cyclin E/Cdk2 substrate nuclear protein ataxia-telangiectasia (NPAT) is involved in regulating histone transcription. J Biol Chem. 290:29290–29300. 2015. View Article : Google Scholar : PubMed/NCBI

53 

Zhao J: Coordination of DNA synthesis and histone gene expression during normal cell cycle progression and after DNA damage. Cell Cycle. 3:693–695. 2004. View Article : Google Scholar : PubMed/NCBI

54 

Lin CY, Lovén J, Rahl PB, Paranal RM, Burge CB, Bradner JE, Lee TI and Young RA: Transcriptional amplification in tumor cells with elevated c-Myc. Cell. 151:56–67. 2012. View Article : Google Scholar : PubMed/NCBI

55 

Miller DM, Thomas SD, Islam A, Muench D and Sedoris K: c-Myc and cancer metabolism. Clin Cancer Res. 18:5546–5553. 2012. View Article : Google Scholar : PubMed/NCBI

56 

Indo Y, Takeshita S, Ishii KA, Hoshii T, Aburatani H, Hirao A and Ikeda K: Metabolic regulation of osteoclast differentiation and function. J Bone Miner Res. 28:2392–2399. 2013. View Article : Google Scholar : PubMed/NCBI

57 

Chen J, Olivares-Navarrete R, Wang Y, Herman TR, Boyan BD and Schwartz Z: Protein-disulfide isomerase-associated 3 (Pdia3) mediates the membrane response to 1,25-dihydroxyvitamin D3 in osteoblasts. J Biol Chem. 285:37041–37050. 2010. View Article : Google Scholar : PubMed/NCBI

58 

Chen E, Xue D, Zhang W, Lin F and Pan Z: Extracellular heat shock protein 70 promotes osteogenesis of human mesenchymal stem cells through activation of the ERK signaling pathway. FEBS Lett. 589:4088–4096. 2015. View Article : Google Scholar : PubMed/NCBI

59 

Kingston RE, Baldwin AS Jr and Sharp PA: Regulation of heat shock protein 70 gene expression by c-myc. Nature. 312:280–282. 1984. View Article : Google Scholar : PubMed/NCBI

60 

Taira T, Sawai M, Ikeda M, Tamai K, Iguchi-Ariga SM and Ariga H: Cell cycle-dependent switch of up-and down-regulation of human hsp70 gene expression by interaction between c-Myc and CBF/NF-Y. J Biol Chem. 274:24270–24279. 1999. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Qian W, Su Y, Zhang Y, Yao N, Gu N, Zhang X and Yin H: Secretome analysis of rat osteoblasts during icariin treatment induced osteogenesis. Mol Med Rep 17: 6515-6525, 2018.
APA
Qian, W., Su, Y., Zhang, Y., Yao, N., Gu, N., Zhang, X., & Yin, H. (2018). Secretome analysis of rat osteoblasts during icariin treatment induced osteogenesis. Molecular Medicine Reports, 17, 6515-6525. https://doi.org/10.3892/mmr.2018.8715
MLA
Qian, W., Su, Y., Zhang, Y., Yao, N., Gu, N., Zhang, X., Yin, H."Secretome analysis of rat osteoblasts during icariin treatment induced osteogenesis". Molecular Medicine Reports 17.5 (2018): 6515-6525.
Chicago
Qian, W., Su, Y., Zhang, Y., Yao, N., Gu, N., Zhang, X., Yin, H."Secretome analysis of rat osteoblasts during icariin treatment induced osteogenesis". Molecular Medicine Reports 17, no. 5 (2018): 6515-6525. https://doi.org/10.3892/mmr.2018.8715
Copy and paste a formatted citation
x
Spandidos Publications style
Qian W, Su Y, Zhang Y, Yao N, Gu N, Zhang X and Yin H: Secretome analysis of rat osteoblasts during icariin treatment induced osteogenesis. Mol Med Rep 17: 6515-6525, 2018.
APA
Qian, W., Su, Y., Zhang, Y., Yao, N., Gu, N., Zhang, X., & Yin, H. (2018). Secretome analysis of rat osteoblasts during icariin treatment induced osteogenesis. Molecular Medicine Reports, 17, 6515-6525. https://doi.org/10.3892/mmr.2018.8715
MLA
Qian, W., Su, Y., Zhang, Y., Yao, N., Gu, N., Zhang, X., Yin, H."Secretome analysis of rat osteoblasts during icariin treatment induced osteogenesis". Molecular Medicine Reports 17.5 (2018): 6515-6525.
Chicago
Qian, W., Su, Y., Zhang, Y., Yao, N., Gu, N., Zhang, X., Yin, H."Secretome analysis of rat osteoblasts during icariin treatment induced osteogenesis". Molecular Medicine Reports 17, no. 5 (2018): 6515-6525. https://doi.org/10.3892/mmr.2018.8715
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team